drugset / Trial / NCT01776463

A Healthy Subject Study With Z-360 and Placebo

NCT01776463 ↗

Phase 1 Completed 43 enrolled Zeria Pharmaceutical
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics (including food effect) of single and multiple doses of Z-360 in healthy Japanese subjects.

Timeline

Start
2013-01
Primary completion
2013-04
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject NASTORAZEPIDE CALCIUM Unknown 60 mg —
Subject NASTORAZEPIDE CALCIUM Unknown 120 mg —
Subject NASTORAZEPIDE CALCIUM Unknown 240 mg —
Subject NASTORAZEPIDE CALCIUM Unknown 480 mg —
Subject NASTORAZEPIDE CALCIUM Unknown 720 mg —

Indications

No indication recorded.